loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Technical details about Linperlisib, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 1702816-75-8, Pi3kdelta-in-2, Pi3k(delta)-in-2, 05hyk3cv9n, Yy-20394, Pi3k
Molecular Formula
C28H37FN6O5S
Molecular Weight
588.7  g/mol
InChI Key
NVWKNQGHVMMAJW-UHFFFAOYSA-N
FDA UNII
05HYK3CV9N

Linperlisib is an orally available selective inhibitor of the delta form of phosphatidylinositol 3-kinase (PI3-kinase subunit delta; PI3K-delta; PI3Kdelta), with potential antineoplastic activity. Upon oral administration linperlisib selectively binds to and inhibits PI3K-delta and prevents the activation of the PI3K/AKT signaling pathway. This decreases proliferation of and induces cell death in PI3K-delta over-expressing tumor cells. PI3K-delta also plays a key role in the B-cell receptor (BCR) signaling pathway and the proliferation of certain hematologic cancer cells. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells, thereby minimizing serious side effects.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide
2.1.2 InChI
InChI=1S/C28H37FN6O5S/c1-28(2,36)20-5-7-34(8-6-20)17-19-13-21(29)15-22-24(31-27(32-25(19)22)35-9-11-40-12-10-35)18-14-23(33-41(4,37)38)26(39-3)30-16-18/h13-16,20,33,36H,5-12,17H2,1-4H3
2.1.3 InChI Key
NVWKNQGHVMMAJW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(C1CCN(CC1)CC2=C3C(=CC(=C2)F)C(=NC(=N3)N4CCOCC4)C5=CC(=C(N=C5)OC)NS(=O)(=O)C)O
2.2 Other Identifiers
2.2.1 UNII
05HYK3CV9N
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1702816-75-8

2. Pi3kdelta-in-2

3. Pi3k(delta)-in-2

4. 05hyk3cv9n

5. Yy-20394

6. Pi3k

7. A-in-2

8. N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide

9. Methanesulfonamide, N-(5-(6-fluoro-8-((4-(1-hydroxy-1-methylethyl)-1-piperidinyl)methyl)-2-(4-morpholinyl)-4-quinazolinyl)-2-methoxy-3-pyridinyl)-

10. N-(5-(6-fluoro-8-((4-(2-hydroxypropan-2-yl) Piperidin-1-yl)methyl)-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-)methanesulfonamide

11. Linperlisib [inn]

12. Pi3kd-in-2

13. Pi3ko-in-2

14. Unii-05hyk3cv9n

15. Pi3k.delta.-in-2

16. Linperlisib [who-dd]

17. Pi3k -in-2

18. Chembl4574601

19. Schembl18032489

20. Gtpl10466

21. Us9656996, Compound 10

22. Bdbm309960

23. Bcp20830

24. Ctc81675

25. Ex-a1436

26. Pi3k(c)(1/2)-in-2

27. Cs-6973

28. Yy20394

29. Compound 10 [us20160244432]

30. Yy-20394; Pi3k

31. A-in-2

32. Ac-35638

33. Hy-102031

34. N-[5-[6-fluoro-8-[[4-(1-hydroxy-1-methylethyl)-1-piperidinyl]methyl]-2-(4-morpholinyl)-4-quinazolinyl]-2-methoxy-3-pyridinyl]-methanesulfonamide

2.4 Create Date
2015-05-04
3 Chemical and Physical Properties
Molecular Weight 588.7 g/mol
Molecular Formula C28H37FN6O5S
XLogP32.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count12
Rotatable Bond Count8
Exact Mass588.25301764 g/mol
Monoisotopic Mass588.25301764 g/mol
Topological Polar Surface Area138 Ų
Heavy Atom Count41
Formal Charge0
Complexity958
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Post Enquiry
POST ENQUIRY